Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAURIS: Atezolizumab + Chemo in ES-SCLC
NCT04028050Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2019
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of atezolizumab in small cell lung cancer (SCLC), sponsored by Roche. Started Aug 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04028050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028050.